Jiangsu Hanbon Science and Technology (688755.SH): Shareholders such as Shanghai Pharmaron, Qingsheng Chi, etc. plan to reduce their total holdings by no more than 3%.
Hanbang Technology (688755.SH) announced that Shanghai Pharming intends to reduce its holdings of the company's shares by no more than 1% of the total share capital, through centralized bidding or block trading, due to its own funding needs, involving up to 114.4 million shares. Qingshi Zhisheng and its concerted action parties plan to collectively reduce their holdings of the company's shares by no more than 2% of the total share capital, through centralized bidding or block trading, involving up to 228.8 million shares, due to their own funding needs.
Jiangsu Hanbon Science and Technology (688755.SH) has announced that Shanghai Pharmaron plans to reduce its holdings of the company's shares by no more than 114,400 shares, representing a total of less than 1% of the company's total share capital, through centralized bidding or block trading due to its own funding needs. Qingsong Zhisheng and its concerted parties also plan to reduce their holdings of the company's shares by no more than 228,800 shares, representing a total of less than 2% of the company's total share capital, through centralized bidding or block trading due to their own funding needs.
Related Articles
Metallurgical Corporation of China (01618) repurchased 2.054 million shares at a cost of HK$2.8752 million on July 3.
PACIFICTEXTILES (01382) has spent HK$346,000 on July 3 to repurchase 403,000 shares.
WEIGAO GROUP (01066) spent approximately 129,600 Hong Kong dollars on July 3 to repurchase 40,000 shares.
Metallurgical Corporation of China (01618) repurchased 2.054 million shares at a cost of HK$2.8752 million on July 3.
PACIFICTEXTILES (01382) has spent HK$346,000 on July 3 to repurchase 403,000 shares.
WEIGAO GROUP (01066) spent approximately 129,600 Hong Kong dollars on July 3 to repurchase 40,000 shares.
RECOMMEND
